Global Bio-Implants Market Size, Share, Growth, Trends and Forecast, 2018-2025 by Data Bridge Market Research


Posted September 26, 2018 by kunalraut

Global Bio-Implants Market is expected to reach USD 308,837.20 million by 2025 from USD 186,162.16 million in 2018, at a CAGR of 7.5% in the forecast period 2018 to 2025.

 
Global Bio-Implants Market is expected to reach USD 308,837.20 million by 2025 from USD 186,162.16 million in 2018, at a CAGR of 7.5% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Free Report Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-bio-implants-market
Segmentation: Global Bio-Implants Market
Product Type
• Orthopedics & Trauma,
• Pacing Devices,
• Stents & Related Implants,
• Spinal Implants,
• Ophthalmic Implants,
• Structural Cardiac Implants,
• Dental Implants,
• Neurostimulators Implants,
• Prosthetic Implants
Type
• Allograft,
• Autograft,
• Xenograft,
• Synthetic
Material
• Biomaterial Metal,
• Alloy,
• Polymer,
• Ceramics,
• Acrylic Hydrogel
Mode Of Administration
• Surgical,
• Non-Surgical
End-User
• Clinics,
• Hospitals,
• Ambulatory Surgical Centers
Geography
• North America,
• Europe,
• Asia-Pacific,
• South America,
• Middle East and Africa
Read Full TOC with Tables at @ https://databridgemarketresearch.com/toc/?dbmr=global-bio-implants-market
Drivers: Global Bio-Implants Market
The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.
RISING INCIDENCE OF CHRONIC DISEASES
There has been gradual demographic transition from patterns of high fertility and mortality to low fertility and delayed mortality rates. As a result of such demographic transitions, the shape of global age distribution is changing. Increase in hypertension, temperature, etc. causes demand for vital sign monitoring devices. High blood pressure can lead to heart diseases, kidney diseases, and heart stroke and also cause death at times.
According to the Centres for Disease Control and Prevention (CDC), about 70.0% of US adults of age 65 or older have high blood pressure and only 50.0% of them have it under control (less than 140/90 mmHg). The high blood pressure causes several diseases like coronary artery disease, dementia, kidney failure, kidney artery aneurysm which is affecting the geriatric population. The diseases leads to disability, low quality of life, increase in health and long term care costs.
Below are some spinal disorders data listed:
• According to National Spinal Cord Injury Statistical Center (NSCSC), Out of the 314 million people in US almost 54.0% of the population is suffering from spinal cord injury (SCI).
• Around 17,000 new cases of the SCI are registered per year in US.
• About 4.0% to 6.0% of the U.S. population is diagnosed with spondylolysis and spondylolisthesis.
• The rising cases of chronic diseases are increasing the implant surgeries to be performed for their treatment which has then grown the number of implants to be manufactured and ultimately it is boosting the market of the bio-implants.
TECHNOLOGICAL ADVANCEMENT IN IMPLANTS
Advancements in technology in the bio-implants market have seen a drastic change over the years. A bio-implant is an implant that comprises of a biological component which is inserted inside the human body. As the technology gets advanced day by day, various new technologies have evolved in the market. For example, 3D printed bio-implants; these are the biological implants which are developed using the biological materials which include cells, protein using bio printing. These implants are called as organ printing because similar autologous cells are used for the reduced rejection by the body and also for reducing the waiting time for the replacement organ.
Inquiry before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bio-implants-market
Major Players: Global Bio-Implants Market
• Abbott Laboratories,
• Medtronic,
• Boston Scientific Corporation,
• Bio-Rad Laboratories, Inc.,
• Somnomed Limited,
• Johnson & Johnson Services, Inc.,
• Edwards Lifesciences Corporation,
• F. Hoffmann-La Roche AG,
• C.R. Bard, Inc.,
• Mimedx Group, Inc.
• Biotronik Se & Co.Kg among others.
For more information about this report visit @ https://databridgemarketresearch.com/news/product-launch/global-bio-implants-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research
Phone +1-888-387-2818
Country India
Categories Business
Tags bioimplants market , bioimplants research report , global bioimplants industry analysis , global bioimplants market research report , global bioimplants research report
Last Updated September 26, 2018